Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $19.07 USD
Change Today +1.20 / 6.72%
Volume 95.6K
LJPC On Other Exchanges
Symbol
Exchange
NASDAQ CM
Stuttgart
As of 8:10 PM 04/20/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

George F. Tidmarsh M.D., Ph.D.

Chief Executive Officer, President and Director, La Jolla Pharmaceutical Co.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 8 different industries.

See Board Relationships
54$2,641,979
As of Fiscal Year 2014

Background*

Dr. George F. Tidmarsh, M.D., Ph.D., has been the Chief Executive Officer and President of La Jolla Pharmaceutical Co. since January 19, 2012. Dr. Tidmarsh served as Secretary of La Jolla Pharmaceutical Co. since January 19, 2012 and served as its Principal Financial Officer and Principal Accounting Officer. Dr. Tidmarsh served as an Executive of Horizon Pharma, Inc. He founded Nuveta Inc. and served as its President and Chief Executive Officer. He founded Metronome ...

Read Full Background

Corporate Headquarters*

4660 La Jolla Village Drive
San Diego, California 92122

United States

Phone: 858-207-4264
Fax: --

Board Members Memberships*

Co-Founder
Former Chief Executive Officer, President and Director
2001-2006
Founder
2011-2012
Former Executive Director
2012-Present
Chief Executive Officer, President and Director

Education*

BS
Stanford University
PhD
Stanford University School of Medicine
MD
Stanford University School of Medicine

Other Affiliations*

Annual Compensation*

Salary$470,000
Bonus$235,000
Total Annual Compensation$705,000

Stock Options*

Unexercisable Options181,000
Total Number of Options181,000

Total Compensation*

Total Annual Cash Compensation$705,000
Total Short Term Compensation$705,000
Total Calculated Compensation$2,641,979
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LJPC:US $19.07 USD +1.20

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LA JOLLA PHARMACEUTICAL CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.